サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402525

アジア太平洋の肺がんスクリーニング市場の2030年までの予測：地域別分析 - がんタイプ、技術、年齢層、エンドユーザー別

Asia Pacific Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
出版日: | 発行: The Insight Partners | ページ情報: 英文 132 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
アジア太平洋の肺がんスクリーニング市場の2030年までの予測：地域別分析 - がんタイプ、技術、年齢層、エンドユーザー別
出版日: 2023年11月01日
発行: The Insight Partners
ページ情報: 英文 132 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の肺がんスクリーニング市場は、2022年の7億1,120万米ドルから2030年には13億6,243万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.5%と推定されます。

構造化された肺がんスクリーニングプログラムがアジア太平洋の肺がんスクリーニング市場を牽引

いくつかの国は肺がんスクリーニングプログラムの課題に直面しています。オーストラリアの集団ベースの検診プログラムの例としては、"BreastScreen"、"National Bowel Cancer Screening Program"、"National Cervical Screening Program"などがあります。

保健省を代表して、RIVM人口検診センター（RIVM-CvB）が全国人口検診プログラムを主導・管理しており、このプログラムでは、すべてのオランダ国民が人生のある時点で、全国検診プログラムのいずれかに参加するよう招待されています。国は3つのがん集団検診プログラムを開始し、設定し、資金を提供します。

そのため、地域ベースのプログラムや、臨床医と潜在的な参加者の間で共有されるインフォームド・デシジョン・プログラム、認定された報告センター、品質管理・モニタリング・結果報告のための中央データ登録など、十分に構造化されたプログラムが極めて重要な要件となります。さらに、統合された禁煙介入、費用対効果を支持する国際的データ、追加的な死亡率ベネフィット、高い持続率は、肺がんスクリーニングのために研究されなければならないいくつかの要因です。さらに、国際肺がん学会は、肺がんスクリーニング研究に参加していないアジア太平洋諸国において、実現可能性のある検診プログラムを実施することを推奨しています。これらのプログラムには、禁煙への取り組み、検診参加者の選択と管理のための標準化されたアルゴリズム、検診結果が陽性であった参加者を管理するための集学的専門家チームが含まれます。したがって、構造化された肺がんスクリーニングプログラムの実施は、予測期間中、肺がんスクリーニング市場における有利な機会となることが期待されます。

アジア太平洋の肺がんスクリーニング市場概要

アジア太平洋の肺がんスクリーニング市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。この地域の成長は、肺がんの罹患率の増加や人々の間でのタバコの喫煙率の増加など、さまざまな要因によるものです。また、検診に対する政府支援の高まりが市場のさらなる成長につながっています。

アジア太平洋の肺がんスクリーニング市場の収益と2030年までの予測（金額）

アジア太平洋の肺がんスクリーニング市場のセグメンテーション

アジア太平洋の肺がんスクリーニング市場は、がん種、技術、年齢層、エンドユーザー、国別に区分されます。

がんの種類に基づいて、アジア太平洋の肺がんスクリーニング市場は、非小細胞肺がん（NSCLC）と小細胞肺がんにセグメント化されます。2022年のアジア太平洋の肺がんスクリーニング市場では、非小細胞肺がん（NSCLC）セグメントが大きなシェアを占めています。

技術に基づき、アジア太平洋の肺がんスクリーニング市場は、胸部X線、低線量コンピュータ断層撮影（LDCT）、リキッドバイオプシー、その他に区分されます。胸部X線セグメントは、2022年のアジア太平洋の肺がんスクリーニング市場で最大のシェアを占めました。

年齢層に基づくと、アジア太平洋の肺がんスクリーニング市場は50歳以上と50歳未満に区分されます。50歳以上セグメントが2022年のアジア太平洋の肺がんスクリーニング市場でより大きなシェアを占めました。

エンドユーザーに基づき、アジア太平洋の肺がんスクリーニング市場は病院、診断センター、その他に区分されます。病院セグメントは2022年にアジア太平洋の肺がんスクリーニング市場で最大のシェアを占めました。

国別では、アジア太平洋の肺がんスクリーニング市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。2022年のアジア太平洋の肺がんスクリーニング市場は中国が独占。

Intelerad Medical Systems Incorporated、Nuance Communications Inc、GE HealthCare Technologies Inc、Medtronic Plc、Canon Medical Systems Corp、Koninklijke Philips NV、Siemens AGは、アジア太平洋の肺がんスクリーニング市場で事業を展開している主要企業の一部です。

目次

第1章 イントロダクション

第2章 アジア太平洋の肺がんスクリーニング市場：要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の肺がんスクリーニング市場：市場情勢

  • アジア太平洋のPEST分析
  • 専門家の見解

第5章 アジア太平洋の肺がんスクリーニング市場：主要市場力学

  • 市場促進要因
    • 肺がん罹患率の上昇
    • 政府支援の増加
  • 市場抑制要因
    • 肺がんスクリーニング検査の高コスト
  • 市場機会
    • 肺がんスクリーニングプログラムの構造化
  • 今後の動向
    • 移動式肺がんスクリーニングトラック
  • 影響分析

第6章 アジア太平洋の肺がんスクリーニング市場：アジア太平洋分析

  • アジア太平洋の肺がんスクリーニング市場の収益と予測分析

第7章 アジア太平洋の肺がんスクリーニング市場-2028年までの収益と予測：がんタイプ別

  • 非小細胞肺がん（NSCLC）
  • 小細胞肺がん

第8章 アジア太平洋の肺がんスクリーニング市場分析：技術別

  • 低線量コンピュータ断層撮影（LDCT）
  • 胸部X線
  • リキッドバイオプシー
  • その他

第9章 アジア太平洋の肺がんスクリーニング市場分析：年齢層別

  • 50歳以上
  • 50歳未満

第10章 アジア太平洋の肺がんスクリーニング市場分析：エンドユーザー別

  • 病院
  • 診断センター
  • その他

第11章 アジア太平洋の肺がんスクリーニング市場-2028年までの収益と予測：国別分析

  • アジア太平洋の肺がんスクリーニング市場

第12章 アジア太平洋の肺がんスクリーニング市場：業界情勢

  • 最近の成長戦略

第13章 企業プロファイル

  • Intelerad Medical Systems
  • Nuance Communications Inc
  • GE HealthCare
  • Medtronic
  • Canon Inc.
  • Koninklijke Philips NV
  • Siemens AG

第14章 付録

図表

List Of Tables

  • Table 1. China: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 2. China: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Japan: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 6. Japan: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. India: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 10. India: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. India: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. India: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Australia: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 14. Australia: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Australia: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Australia: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. South Korea: Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 18. South Korea: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. South Korea: Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. South Korea: Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 22. Rest of Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Recent Growth Strategies in the Asia Pacific Lung Cancer Screening Market
  • Table 26. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Lung Cancer Screening Market Segmentation
  • Figure 2. Asia Pacific Lung Cancer Screening Market, by Country
  • Figure 3. Asia Pacific Lung Cancer Screening Market Overview
  • Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Asia Pacific Lung Cancer Screening Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Asia Pacific Lung Cancer Screening Market Impact Analysis of Driver and Restraints
  • Figure 9. Asia Pacific Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 10. Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • Figure 11. Non-Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Asia Pacific Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
  • Figure 14. Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Chest X-ray: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Liquid Biopsy: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Asia Pacific Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
  • Figure 19. 50 & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Asia Pacific Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 26. Asia Pacific Lung Cancer Screening Market Revenue Share, by Country, 2022 & 2030 (%)
  • Figure 27. China: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Japan: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. India: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Australia: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. South Korea: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
目次
Product Code: BMIRE00029045

The Asia Pacific lung cancer screening market is expected to grow from US$ 711.20 million in 2022 to US$ 1,362.43 million by 2030. It is estimated to grow at a CAGR of 8.5% from 2022 to 2030.

Structured Lung Cancer Screening Program Fuel Asia Pacific lung Cancer Screening Market

Several countries face challenges with lung cancer screening programs. A few examples of population-based Australian screening programs are "BreastScreen," the "National Bowel Cancer Screening Program," and the "National Cervical Screening Program."

On behalf of the Ministry of Health, the RIVM Center for Population Screening (RIVM-CvB) leads and manages the National Population Screening Programme; under which all Dutch citizens are invited, at a certain point in their lives, to participate in one of the national screening programs. The State begins, sets up, and finances three cancer population screening programs.

Therefore, there is a crucial requirement for a well-structured program such as a community-based program or a shared, informed decision-making program between clinicians and potential participants; accredited reporting centers; and a central data registry for quality control, monitoring, and outcome reporting. Additionally, integrated smoking cessation intervention, international data supporting cost-effectiveness, additional mortality benefits, and a high sustainability rate are a few factors that must be studied for lung cancer screening. Further, the International Association for the Study of Lung Cancer recommends implementing feasibility screening programs in the countries of Asia Pacific without participating in lung cancer screening studies. These programs involve smoking cessation initiatives, standardized algorithms for selecting and managing screening participants, and specialist multidisciplinary teams to manage participants with positive screening results. Therefore, the implementation of structured lung cancer screening programs is expected to be a lucrative opportunity in the lung cancer screening market during the forecast period.

Asia Pacific Lung Cancer Screening Market Overview

The Asia Pacific lung cancer screening market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and growing prevalence of cigarette smoking among people. Also, rising government support for screening has led to the further growth of the market.

Asia Pacific lung cancer screening market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Lung Cancer Screening Market Segmentation

The Asia Pacific lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.

Based on cancer type, the Asia Pacific lung cancer screening market is segmented into Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the Asia Pacific lung cancer screening market in 2022.

Based on technology, the Asia Pacific lung cancer screening market is segmented into chest x-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Chest x-ray segment held the largest share of the Asia Pacific lung cancer screening market in 2022.

Based on age group, the Asia Pacific lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the Asia Pacific lung cancer screening market in 2022.

Based on end user, the Asia Pacific lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the Asia Pacific lung cancer screening market in 2022.

Based on country, the Asia Pacific Lung Cancer Screening Market is segmented into China Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific lung cancer screening market in 2022.

Intelerad Medical Systems Incorporated, Nuance Communications Inc, GE HealthCare Technologies Inc, Medtronic Plc, Canon Medical Systems Corp, Koninklijke Philips NV, and Siemens AG are some of the leading companies operating in the Asia Pacific lung cancer screening market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Lung Cancer Screening Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Lung Cancer Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Lung Cancer Screening Market - by Technology
    • 1.3.2 Asia Pacific Lung Cancer Screening Market - by Cancer Type
    • 1.3.3 Asia Pacific Lung Cancer Screening Market - by Age Group
    • 1.3.4 Asia Pacific Lung Cancer Screening Market - by End User
    • 1.3.5 Asia Pacific Lung Cancer Screening Market - by Country

2. Asia Pacific Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Lung Cancer Screening Market - Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Lung Cancer Screening Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Lung Cancer Incidences
    • 5.1.2 Increasing Government Support
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Lung Cancer Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Structured Lung Cancer Screening Program
  • 5.4 Future Trends
    • 5.4.1 Mobile Lung Cancer Screening Truck
  • 5.5 Impact Analysis

6. Asia Pacific Lung Cancer Screening Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Lung Cancer Screening Market Revenue Forecast and Analysis

7. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

  • 7.1 Overview
  • 7.2 Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • 7.3 Non-Small Cell Lung Cancer (NSCLC)
    • 7.3.1 Overview
    • 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
  • 7.4 Small Cell Lung Cancer
    • 7.4.1 Overview
    • 7.4.2 Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Lung Cancer Screening Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Low-Dose Computed Tomography (LDCT)
    • 8.2.1 Overview
    • 8.2.2 Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chest X-ray
    • 8.3.1 Overview
    • 8.3.2 Chest X-ray: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid Biopsy
    • 8.4.1 Overview
    • 8.4.2 Liquid Biopsy: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Asia Pacific Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lung Cancer Screening Market Analysis - by Age Group

  • 9.1 Overview
  • 9.2 & Older
    • 9.2.1 Overview
    • 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Below 50
    • 9.3.1 Overview
    • 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Lung Cancer Screening Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis

  • 11.1 Asia Pacific Lung Cancer Screening Market
      • 11.1.1.1 China: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 China: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.3 China: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.1.4 China: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.5 China: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.1.6 China: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.2 Japan: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Japan: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.3 Japan: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.2.4 Japan: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.5 Japan: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.2.6 Japan: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 India: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 India: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.3 India: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.3.4 India: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.5 India: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.3.6 India: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.4 Australia: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 Overview
        • 11.1.1.4.2 Australia: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.3 Australia: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Australia: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.5 Australia: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.4.6 Australia: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.5 South Korea: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Overview
        • 11.1.1.5.2 South Korea: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.3 South Korea: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.5.4 South Korea: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.5 South Korea: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.5.6 South Korea: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.6 Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.6.1 Overview
        • 11.1.1.6.2 Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.6.3 Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.1.6.4 Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.6.5 Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.1.6.6 Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. Asia Pacific Lung Cancer Screening Market-Industry Landscape

  • 12.1 Recent Growth Strategies
    • 12.1.1 Overview

13. Company Profiles

  • 13.1 Intelerad Medical Systems
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Nuance Communications Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 GE HealthCare
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Medtronic
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Canon Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Koninklijke Philips NV
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Siemens AG
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms